Bitter medicine: COVID-19 has exposed pitfalls of Indian pharma’s over-dependence on Chinese API

The Katoch committee, in 2015, had proposed several measures like setting up parks for API, providing capex, and subsidised loans to boost domestic production of APIs.

from The Financial Express https://ift.tt/3cgSMl9